John Öhd

1.1k total citations
30 papers, 883 citations indexed

About

John Öhd is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, John Öhd has authored 30 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in John Öhd's work include Inflammatory mediators and NSAID effects (9 papers), Estrogen and related hormone effects (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). John Öhd is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Estrogen and related hormone effects (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). John Öhd collaborates with scholars based in Sweden, United States and United Kingdom. John Öhd's co-authors include Anita Sjölander, Katarina Wikström, Christian Kamp Nielsen, Göran Landberg, Joan Campbell-Tofte, Helge Löfberg, Jonas Bergh, Matthias Mörgelin, Kristian Riesbeck and Hans Nordgren and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

John Öhd

30 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Öhd Sweden 16 361 261 223 175 122 30 883
Peter Hammarsten Sweden 19 482 1.3× 261 1.0× 198 0.9× 273 1.6× 69 0.6× 27 1.2k
Akira Morimiya United States 11 628 1.7× 504 1.9× 108 0.5× 343 2.0× 47 0.4× 16 1.1k
Kaiming Xu United States 14 309 0.9× 124 0.5× 113 0.5× 97 0.6× 33 0.3× 22 589
Earl Lawrence United States 12 733 2.0× 320 1.2× 328 1.5× 257 1.5× 25 0.2× 14 1.5k
Raymond Tabibiazar United States 17 473 1.3× 265 1.0× 261 1.2× 87 0.5× 25 0.2× 24 1.3k
John E. Pawlowski United States 17 555 1.5× 103 0.4× 72 0.3× 85 0.5× 28 0.2× 25 1.2k
John Yates United Kingdom 9 918 2.5× 363 1.4× 67 0.3× 141 0.8× 27 0.2× 10 1.5k
G. Butti Italy 21 339 0.9× 212 0.8× 70 0.3× 212 1.2× 36 0.3× 55 1.1k
Yuko Takeba Japan 19 342 0.9× 197 0.8× 56 0.3× 87 0.5× 133 1.1× 48 946
Terumi Kambe Japan 7 666 1.8× 77 0.3× 261 1.2× 123 0.7× 23 0.2× 8 1.0k

Countries citing papers authored by John Öhd

Since Specialization
Citations

This map shows the geographic impact of John Öhd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Öhd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Öhd more than expected).

Fields of papers citing papers by John Öhd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Öhd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Öhd. The network helps show where John Öhd may publish in the future.

Co-authorship network of co-authors of John Öhd

This figure shows the co-authorship network connecting the top 25 collaborators of John Öhd. A scholar is included among the top collaborators of John Öhd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Öhd. John Öhd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asperti, Michela, Magdalena Gryzik, Kristina E. M. Persson, et al.. (2024). Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers. HemaSphere. 8(12). e70035–e70035. 1 indexed citations
2.
Asperti, Michela, Magdalena Gryzik, Manuela Cominelli, et al.. (2023). The Heparinoid Sevuparin Improves Anemia and Kidney Status in a Mouse Model of Chronic Kidney Disease. Blood. 142(Supplement 1). 2463–2463. 2 indexed citations
3.
Conaghan, Philip G., Sarah R. Kingsbury, Allan S. Brett, et al.. (2019). Safety and efficacy of six months' open label extension post-RCT using the novel cathepsin K inhibitor MIV-711 in patients with knee osteoarthritis. Osteoarthritis and Cartilage. 27. S501–S502. 2 indexed citations
4.
Schilder, Russell J., et al.. (2018). A phase 1/2 study with birinapant in combination with pembrolizumab.. Journal of Clinical Oncology. 36(15_suppl). TPS3131–TPS3131. 3 indexed citations
5.
Conaghan, Philip G., Sarah R. Kingsbury, Allan S. Brett, et al.. (2018). Six months’ treatment with MIV-711, a novel Cathepsin K inhibitor induces osteoarthritis structure modification: results from a randomized double-blind placebo-controlled phase IIA trial. Osteoarthritis and Cartilage. 26. S25–S26. 15 indexed citations
6.
Kolmert, Johan, Johan Lindberg, John Öhd, et al.. (2014). A quantitative LC/MS method targeting urinary 1-methyl-4-imidazoleacetic acid for safety monitoring of the global histamine turnover in clinical studies. Analytical and Bioanalytical Chemistry. 406(6). 1751–1762. 7 indexed citations
7.
Jučaitė, Aurelija, John Öhd, Alexandra Potter, et al.. (2013). A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. Psychopharmacology. 231(6). 1251–1265. 24 indexed citations
8.
Boström, Emma, et al.. (2013). Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers. Clinical Pharmacology in Drug Development. 3(1). 63–71. 2 indexed citations
9.
Bergqvist, Jenny, John Öhd, Johanna Smeds, et al.. (2007). Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome. Annals of Oncology. 18(5). 845–850. 31 indexed citations
10.
Villman, Kenneth, John Öhd, Elisabet Lidbrink, et al.. (2007). A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer. European Journal of Cancer. 43(7). 1153–1160. 18 indexed citations
11.
Bergqvist, Jenny, Göran Elmberger, John Öhd, et al.. (2006). Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen. European Journal of Cancer. 42(8). 1104–1112. 43 indexed citations
12.
Wikström, Katarina, et al.. (2006). The Inflammatory Mediator Leukotriene D4 Induces β-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells. Journal of Biological Chemistry. 281(10). 6776–6784. 50 indexed citations
13.
Hall, Per, Alexander Ploner, Judith Bjöhle, et al.. (2006). Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Medicine. 4(1). 16–16. 51 indexed citations
14.
Andersson, J., Lena Larsson, Sigrid Klaar, et al.. (2005). Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF. Annals of Oncology. 16(5). 743–748. 46 indexed citations
15.
Nielsen, Christian Kamp, John Öhd, Katarina Wikström, et al.. (2003). The Leukotriene Receptor CYSLT1 And 5- Lipoxygenase Are Upregulated In Colon Cancer. Advances in experimental medicine and biology. 525. 201–204. 30 indexed citations
16.
Öhd, John, Christian Kamp Nielsen, Joan Campbell-Tofte, et al.. (2003). Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology. 124(1). 57–70. 156 indexed citations
17.
Wikström, Katarina, John Öhd, & Anita Sjölander. (2003). Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2. Biochemical and Biophysical Research Communications. 302(2). 330–335. 25 indexed citations
18.
Öhd, John, Katarina Wikström, & Anita Sjölander. (2002). Do Leukotrienes Increase Cell Viability in Human Intestinal Epithelial Cells?. Advances in experimental medicine and biology. 507. 193–198. 3 indexed citations
19.
Öhd, John, Katarina Wikström, & Anita Sjölander. (2000). Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology. 119(4). 1007–1018. 95 indexed citations
20.
Öhd, John, et al.. (1996). Leukotriene D4-Induced Activation and Translocation of the G-Protein αi3-Subunit in Human Epithelial Cells. Biochemical and Biophysical Research Communications. 226(2). 413–419. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Hammarsten Breakdown of academic impact, for papers by Akira Morimiya Breakdown of academic impact, for papers by Kaiming Xu Breakdown of academic impact, for papers by Earl Lawrence Breakdown of academic impact, for papers by Raymond Tabibiazar Breakdown of academic impact, for papers by John E. Pawlowski Breakdown of academic impact, for papers by John Yates Breakdown of academic impact, for papers by G. Butti Breakdown of academic impact, for papers by Yuko Takeba Breakdown of academic impact, for papers by Terumi Kambe
Rankless by CCL
2026